Cambium Bio

Cambium Bio (CMB), formerly Regeneus Limited, is a Sydney-based regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases.

Contact Details

16 Goodhope Street , PADDINGTON NSW 2021

1300 995 098

info@cambium.bio

www.cambium.bio

Lists and Charts

Share price

Cambium Bio
Closing price for the last 90 trading days

View ASX Chart

Revenue

Rank		Company	#
1006^th	-	Cambium Bio	$1.06m

1301 public companies - non WA ranked by total revenue

View Full List

Company Share Transactions

Company Activity

	NEWS: Tagged in Regeneus trebles on back of merger deal	05 Apr 2024
	NEW ROLE: John Chiplin, Non-Executive Director	03 Nov 2020
	NEW ROLE: Graham Vesey, Chief Scientific Officer, Executive Director	03 Nov 2020
	NEW ROLE: Alan Dunton, Non-Executive Director	03 Nov 2020
	NEW ROLE: Leo Lee, Non-Executive Director	03 Nov 2020
	NEW ROLE: Sandra McIntosh, Company Secretary	03 Nov 2020
	NEW ROLE: Karolis Rosickas, Chief Executive Officer	03 Nov 2020
	NEW ROLE: Barry Sechos, Non-Executive Director, Chair since 2019	03 Nov 2020

Related Information

Access to our data for Cambium Bio is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Cambium Bio is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today